Your browser doesn't support javascript.
loading
Enhanced molecular mobility of ordinarily structured regions drives polyglutamine disease.
Lupton, Christopher J; Steer, David L; Wintrode, Patrick L; Bottomley, Stephen P; Hughes, Victoria A; Ellisdon, Andrew M.
Afiliação
  • Lupton CJ; From the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, and.
  • Steer DL; From the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, and.
  • Wintrode PL; the Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201.
  • Bottomley SP; From the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, and.
  • Hughes VA; From the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, and the Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Melbourne, Victoria, Australia, 3800 and victoria.hughes@monash.edu.
  • Ellisdon AM; From the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, and the Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Melbourne, Victoria, Australia, 3800 and andrew.ellisdon@monash.edu.
J Biol Chem ; 290(40): 24190-200, 2015 Oct 02.
Article em En | MEDLINE | ID: mdl-26260925
ABSTRACT
Polyglutamine expansion is a hallmark of nine neurodegenerative diseases, with protein aggregation intrinsically linked to disease progression. Although polyglutamine expansion accelerates protein aggregation, the misfolding process is frequently instigated by flanking domains. For example, polyglutamine expansion in ataxin-3 allosterically triggers the aggregation of the catalytic Josephin domain. The molecular mechanism that underpins this allosteric aggregation trigger remains to be determined. Here, we establish that polyglutamine expansion increases the molecular mobility of two juxtaposed helices critical to ataxin-3 deubiquitinase activity. Within one of these helices, we identified a highly amyloidogenic sequence motif that instigates aggregation and forms the core of the growing fibril. Critically, by mutating residues within this key region, we decrease local structural fluctuations to slow ataxin-3 aggregation. This provides significant insight, down to the molecular level, into how polyglutamine expansion drives aggregation and explains the positive correlation between polyglutamine tract length, protein aggregation, and disease severity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Doença de Machado-Joseph / Ataxina-3 Limite: Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Doença de Machado-Joseph / Ataxina-3 Limite: Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2015 Tipo de documento: Article